nivolumab,ipilimumab,cabozantinib
bms
['opacin-neo', 'irene', 'nsclc', 'sclc']
grab a cup of and check out this popular #jitc review on neoadjuvant io for nsclc from elizabeth ahren ( ) et al as you make your way to hear irene lm reijers of present three-year data of prado and opacin-neo at #asco23. 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)